Measures of anticoagulation and coagulopathy in pediatric cardiac extracorporeal membrane oxygenation patients.
Mouhammad YabrodiCarrie CiccotelloAjay K BhatiaJoel DavisKevin O MaherShriprasad R DeshpandePublished in: The International journal of artificial organs (2020)
Coagulation monitoring on ECMO may benefit from addition of Heparinase TEG to diagnose covert coagulopathy which can contribute to significant hemorrhagic complications. There is a need for a prospective, thromboelastography guided intervention trial to reduce coagulopathy related morbidity and mortality in ECMO.
Keyphrases
- extracorporeal membrane oxygenation
- acute respiratory distress syndrome
- respiratory failure
- end stage renal disease
- ejection fraction
- chronic kidney disease
- newly diagnosed
- clinical trial
- mechanical ventilation
- heart failure
- left ventricular
- study protocol
- risk factors
- phase iii
- patient reported outcomes
- young adults